Becton Dickinson & Co.: Medical Device Recall in 2024 - (Recall #: Z-1020-2024)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2024.

Data Source: FDA.

Product Description:

BD BBL Sensi Disc Cefotaxime - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607¿; 5 ug, Catalog No. 291308¿

Product Classification:

Class II

Date Initiated: January 8, 2024

Date Posted: February 14, 2024

Recall Number: Z-1020-2024

Event ID: 93789

Reason for Recall:

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

Status: Ongoing

Product Quantity: 2,363,168 total units

Code Information:

Catalog No. 231606 UDI-DI 00382902316060 Lots 2004580 2025164 2090467 2146516 2180432 2301360 3003886; Catalog No. 231607 UDI-DI 30382902316078 Lots 2301360 3062270 3158078 3261093 2004580 2025164 2090467 2146516 2180432 3003886; Catalog No. 291308¿ UDI-DI N/A Lots 2301468 3003046 3093596 3116037 3248537 3248540

Distribution Pattern:

Domestic distribution nationwide. International distribution worldwide.

Voluntary or Mandated:

Voluntary: Firm initiated